The U.S. District Court for the Northern District of West Virginia has ruled in favor of Merck in a patent infringement suit against Viatris related to sitagliptin, an active ingredient in Januvia, ...
OSAKA, TOKYO, Dec. 12, 2007-Ono Pharmaceutical Co., Ltd. (Osaka, Japan, President: Toshiharu Korekane) and Banyu Pharmaceutical Co., Ltd. (Tokyo, Japan, President ...
Janumet™ (MK-0431A) combines two OADs with complementary mechanisms of action to improve glycemic control, sitagliptin and metformin. The tablet was designed in order to be bioequivalent to ...
The Multi Disciplinary Committee (MDC) of Experts advising the National Pharmaceutical Pricing Authority (NPPA) has fixed the retail price of anti-diabetes drug combinations comprising sitagliptin and ...
Please provide your email address to receive an email when new articles are posted on . Adults with type 2 diabetes who were hospitalized with COVID-19 in northern Italy had a lower mortality rate and ...
New data presented at the American Diabetes Association 70 th Annual Scientific Sessions WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)-- New data were presented at the American Diabetes Association (ADA) ...
Sitagliptin and glipizide monotherapy is safe and effective in patients with type 2 diabetes and end-stage renal disease (ESRD) requiring dialysis, researchers reported online ahead of print in the ...
RAHWAY, N.J.--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside of the United States and Canada, announced today that the U.S. Court of Appeals for the Federal Circuit ruled in favor of the ...
RAHWAY, N.J.--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside of the United States and Canada, announced today that the U.S. District Court for the Northern District of West Virginia ruled in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback